Inhibition by Omeprazole of Proguanil Metabolism: Mechanism of the Interaction In Vitro and Prediction of In Vivo Results from the In Vitro Experiments

This publication has 47 references indexed in Scilit:

• Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians*
  Clinical Pharmacology & Therapeutics, 1996
• Human cytochromes P450 expressed in Escherichia coli: production of specific antibodies
  Toxicology, 1996
• Comparison of chloroguanide and mephenytoin for the in vivo assessment of genetically determined CYP2C19 activity in humans*
  Clinical Pharmacology & Therapeutics, 1995
• The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: A population study*
  Clinical Pharmacology & Therapeutics, 1995
• Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide
  Biochemical Pharmacology, 1994
• Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes
  Biochemical Pharmacology, 1992
• Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990
• Genetic polymorphism of S-mephenytoin hydroxylation
  Pharmacology & Therapeutics, 1989
• Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987
• Determination of drug metabolizing enzymes in needle biopsies of human liver
  European Journal of Clinical Pharmacology, 1972